Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets

被引:56
作者
Erotokritou-Mulligan, Ioulietta
Bassett, E. Eryl
Kniess, Astrid
Sonksen, Peter H.
Holt, Richard I. G.
机构
[1] Univ Southampton, Sch Med, Endocrinol & Metab Sub Div, Southampton SO16 6YD, Hants, England
[2] Univ Kent, Inst Math Stat & Acturial Sci, Canterbury, Kent, England
[3] Inst Doping Anal & Sportbiochem, Kreicha, Germany
关键词
growth hormone; sport; abuse; discriminant function; markers;
D O I
10.1016/j.ghir.2007.04.013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Context: The detection of exogenously administered growth hormone (GH) poses a formidable challenge but a detection method based on the measurement of two GH-dependent markers, IGF-I and type 3 pro-collagen (P-III-P) has been proposed. The measurement of multiple markers in conjunction with discriminant functions can improve the sensitivity and specificity of detection compared with single marker analysis. Objective: To provide further validation of the GH-dependent marker approach. Design: Analysis of discriminant function scores for GH detection on independent datasets. Setting: Two independent (GH-2000 and Kreischa) double blind, placebo controlled, hGH administration studies. Subjects: Healthy active male volunteers. Intervention: GH-2000 proposed a discriminant function involving IGF-I and P-III- P while the Kreischa function involved IGF-I, P-III-P and IGFBP-3. After adjustment for assay differences the formulae were applied to the other dataset. Outcome measures: Ability to detect GH use in independent datasets using a predefined specificity of approximately 1 in 10000. Results: The GH-2000 formula was able to detect 90% of those receiving GH in the Kreischa study at one or more time points during the study period. This sensitivity was similar to that obtained on the original GH-2000 dataset. The Kreischa formula correctly identified 41% of individuals receiving GH in the GH-2000 study. Conclusions: The study provides further validation that the test proposed by GH-2000 based on IGF-I and P-III-P concentrations can be used to detect subjects receiving exogenous GH. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:416 / 423
页数:8
相关论文
共 20 条
  • [1] Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport
    Abellan, R
    Ventura, R
    Pichini, S
    Pascual, JA
    Pacifici, R
    Di Carlo, S
    Bacosi, A
    Segura, J
    Zuccaro, P
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (01) : 75 - 85
  • [2] Test method: GH
    Bidlingmaier, M
    Wu, ZD
    Strasburger, CJ
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 14 (01) : 99 - 109
  • [3] The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men
    Dall, R
    Longobardi, S
    Ehrnborg, C
    Keay, N
    Rosén, T
    Jorgensen, JOL
    Cuneo, RC
    Boroujerdi, MA
    Cittadini, A
    Napoli, R
    Christiansen, JS
    Bengtsson, BA
    Sacca, L
    Baxter, RC
    Basset, EE
    Sönksen, PH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) : 4193 - 4200
  • [4] The growth hormone/insulin-like growth factor-1 axis hormones and bone markers in elite athletes in response to a maximum exercise test
    Ehrnborg, C
    Lange, KHW
    Dall, R
    Christiansen, JS
    Lundberg, PA
    Baxter, RC
    Boroujerdi, MA
    Bengtsson, BA
    Healey, ML
    Pentecost, C
    Longobardi, S
    Napoli, R
    Rosén, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) : 394 - 401
  • [5] *GH 2000 GROUP, 2006, FIN REP INT OL COMM
  • [6] Goodall Ian, 2005, Clin Biochem Rev, V26, P5
  • [7] Toward the development of a test for growth hormone (GH) abuse:: A study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting
    Healy, ML
    Dall, R
    Gibney, J
    Bassett, E
    Ehrnborg, C
    Pentecost, C
    Rosen, T
    Cittadini, A
    Baxter, RC
    Sönksen, PH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) : 641 - 649
  • [8] Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle
    Juul, A
    Scheike, T
    Pedersen, AT
    Main, KM
    Andersson, AM
    Pedersen, LM
    Skakkebaek, NE
    [J]. HUMAN REPRODUCTION, 1997, 12 (10) : 2123 - 2128
  • [9] Juul A, 2005, FRONT HORM RES, V33, P45, DOI 10.1159/000088406
  • [10] Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex
    Kam, GYW
    Leung, KC
    Baxter, RC
    Ho, KKY
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) : 1918 - 1922